News Releases

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

News tagged ‘OvarianCancer’ clear

  • Dana-Farber/Brigham and Women's Cancer Center and the Massachusetts Ovarian Cancer Awareness Coalition want women to get the facts and recognize the signs of the disease.

Tags: OvarianCancer, GynecologicCancers

  • Dana-Farber scientists find when given together, two orally available experimental drugs – sapacitabine and seliciclib – worked together to elicit antitumor effects in patients with incurable BRCA-deficient cancers.

Tags: BasicResearch, BreastCancer, OvarianCancer, PancreaticCancer, GynecologicCancers

  • A new study that proposes a three-in-one test for gynecologic cancers underscores the promise of molecular screening for early detection of endometrial and ovarian cancers, but also suggests that such tests are not yet ready for clinical use. Andrea Myers, MD, PhD, a co-author of the commentary on the study, says the test is an important step in that direction.

Tags: CervicalCancer, OvarianCancer, Prevention, GynecologicCancers

  • Dana-Farber researchers find novel antibody-guided drug achieves responses in platinum drug-resistant ovarian cancer.

Tags: BasicResearch, OvarianCancer, GynecologicCancers

  • One of the shortcomings of a therapy that uses millions of identical antibodies to boost the immune system's attack on cancer cells is that many patients whose tumors recede in response to the treatment also experience serious inflammatory problems, such as severe diarrhea and rashes. In a new study, a team led by Dana-Farber Cancer Institute researchers shows that giving periodic infusions of such "monoclonal" antibodies to patients who have received a widely used cancer vaccine unleashes a strong immune response to tumors, with less-harsh side effects.

Tags: Melanoma, OvarianCancer, TargetedTherapy

Showing 11-15 of 15 items